cobicistat will boost the stage or effect of bortezomib by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Observe.
fluconazole will boost the degree or influence of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Keep an eye on.
Acute respiratory distress syndrome (ARDS) and acute diffuse infiltrative pulmonary disease of not known etiology for instance pneumonitis, interstitial pneumonia, lung infiltration have transpired
Check Carefully (one)triclabendazole will enhance the stage or result of bortezomib by impacting hepatic enzyme CYP2C19 metabolism.
istradefylline will boost the amount or effect of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Keep an eye on.
Irrespective of currently being a chief, two is additionally a extremely composite selection, as it has far more divisors as opposed to number one. The next remarkably composite range is four.
posaconazole will raise the level or influence of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
fosamprenavir will increase the level or effect of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Observe.
zafirlukast will enhance the amount or outcome of bortezomib by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
butalbital will reduce the extent or outcome of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Caution/Check.
cimetidine will enhance the amount or effect of bortezomib by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Use Warning/Watch.
Wherever STDOUT experience a specific filter, STDERR to a different and finally the two outputs merged undergo a third command filter.
; the Lin281632 worth in the guess has an effect on only the amount of iterations are necessary to get to an approximation of a certain precision. Then, working with that guess, iterate by the Verteporfin next recursive computation:
Observe Closely (one)ponesimod and bortezomib each raise immunosuppressive results; chance of an infection. Use Warning/Keep track of. CDK4/6-IN-6 Caution if coadministered because of additive immunosuppressive outcomes during these types of therapy and while in the months following administration.